Crossmark

Cost-effectiveness of expanding the target population of biennial screening for breast cancer from ages 50–69 to 45 and/or 74: A cohort modelling study in the Finnish setting

Crossref DOI link: https://doi.org/10.1186/s13561-025-00628-5

Published Online: 2025-04-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Siegfrids, Filip

Heinävaara, Sirpa

Sarkeala, Tytti

Niinikoski, Laura

Laine, Juha
Funding

Funding for this research was provided by:

Cancer Foundation Finland (200080)
License Information

Text and Data Mining valid from 2025-04-11

Version of Record valid from 2025-04-11
More Information

Article History

Received: 23 May 2024

Accepted: 4 April 2025

First Online: 11 April 2025

Declarations

:

: Not applicable.

: Not applicable.

: Tytti Sarkeala is a member of the National Screening Board. Sirpa Heinävaara and Laura Niinikoski are members of the National Advisory Group for Breast Cancer Screening.

Document is current

Any future updates will be listed below